First Header Logo Second Header Logo

Connection

Agshin Taghiyev to Receptors, Tumor Necrosis Factor

This is a "connection" page, showing publications Agshin Taghiyev has written about Receptors, Tumor Necrosis Factor.
  1. Rokhlin OW, Glover RA, Taghiyev AF, Guseva NV, Seftor RE, Shyshynova I, Gudkov AV, Cohen MB. Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcription. J Biol Chem. 2002 Sep 06; 277(36):33213-9.
    View in: PubMed
    Score: 0.052
  2. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Syrbu SI, Cohen MB. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther. 2002; 1(6):631-7.
    View in: PubMed
    Score: 0.051
  3. Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Breast Cancer Res Treat. 2008 Feb; 107(3):349-57.
    View in: PubMed
    Score: 0.018
  4. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE, Cohen MB. Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene. 2005 Oct 13; 24(45):6773-84.
    View in: PubMed
    Score: 0.016
  5. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell lines. Cancer Biol Ther. 2004 Aug; 3(8):761-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.